The Cannabis Investing Podcast

The CBD market has recently seen a multi-billion dollar deal and HempFusion going public. HempFusion Co-Founder/CEO Dr. Jason Mitchell and CCO Danny Brody join Rena Sherbill to discuss radical transparency, methodical growth and becoming more efficient during Covid. We also cover the opportunity in probiotics and hemp. Doing things right as opposed to Right Away and why expansion is absolute. Lear...

In a troubling and unpredictable year, blockchain and cannabis have been some of the best investments and two industries most primed for growth. Chris Naprawa, Director and Chairman of the Board at Khiron and President at TAAL Distributed Information Technologies, shares his insights on both paradigm-shifting industries. Why BSV is the protocol of the future, and why TAAL is in position to capital...

Talking CBD, hemp, cannabinoids in the health and wellness segment with Smoke Wallin, CEO of Vertical Wellness. Many regulatory headwinds, but near-term hemp and CBD saturation will open up and level off. FDA still captive to pharma industry. Bigger opportunity for natural products industry. Essential to know how to operate in a regulated market. Cannabis beverages - bullish over long-term, many i...

CEO Jonathan Sandelman returns to the show to discuss AYR Strategies' recent deals and its steady rise to the top of the MSO pack. 7 M&A transactions in past 4 months. Very accretive deals for shareholders: great assets at a fair price. Want partners and shareholders to be excited to partner with AYR. AYR stock a big reason companies do deals with them. Importance of the flower. Why change in US p...

SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient funding process. going the SPAC route. Cannabis grown in Colombia, being GMP-certified, LatAm region makes sense especially for extraction use. Cannabis on a global stage. Learn more about your ad choices. Visit me...

It's SPAC week and why not start with Subversive Capital and the biggest cannabis SPAC ever, launching this week: The Parent Company. Subversive Founder and Chairman Michael Auerbach joins Rena Sherbill to discuss California as the tip of the spear and why it was always the focus. Creating a generational company and real change. Shared social equity vision with Jay-Z. Consolidating and dominating...

Cannabis is reaching more people in more ways and recent US elections show the green rush is here to stay. But what about Canada? Jeff Fallows, President of The Valens Company, explains why he came on board - what they're doing differently and better than its Canadian peers. Cycle of improvement; operational efficiencies, better cost profile, leading the charge of cannabis 3.0 and next generation...

Israel is the largest consumer of medical cannabis in the world, but regulatory progress towards full legalization is moving slowly. Saul Kaye, CEO and founder of iCAN, talks Israel's rapidly developing cannabis market and why regulators shouldn't forget the underground market. Setting up supply chains in Israel and Europe. Psychedelics, cannabis and treating mental health. Learn more about your a...

Our Master Class returns with two terrific SA authors and investors in the cannabis space: James V. Baker and Julian Lin. We cover the US cannabis space and why P/E multiples don't make any sense; out of whack valuations. Coming soon: 100 bagger stocks; issuing debt vs selling stock. Cannabis investors need to be better educated. the absurdity of 280E. Covering the ETF MSOS, derivatives and option...

Columbia Care CEO and co-founder Nicholas Vita shares his thoughts on disproportionate growth, and why private equity may be the next big thing to get into cannabis. State laws dictate federal laws, which has only been exacerbated by Covid. Columbia Care is the leader in the Mid-Atlantic and readying for staggering growth in the East Coast. Headlines are great but integration is hard, driving real...

We are on the cusp of another burst of M&A in the cannabis industry, but one grounded more in fiscal responsibilities. Scott Hammon, partner and leader of the cannabis practice at MGO, joins Rena Sherbill to discuss this trend amidst the rapidly maturing cannabis industry. We also cover why companies are putting a stronger emphasis on regional footprints over a national one; good operators will be...

Celebrating our 100th episode! Alvaro Torres, co-founder and CEO of Khiron, joins us to discuss building value in LatAm and Europe and why a strong foundation is essential. Following its recent Q3 earnings and some bullish announcements, we also cover why Khiron wanted to avoid treating cannabis as a commodity. Sustainable patient growth with good margins. Staying the course. Slow, but present, Eu...

Fresh off record earnings, Planet 13 continues to build on investors' excitement about cannabis in general and the US in particular. Co-CEO Bob Groesbeck talks to Rena Sherbill about being positioned for growth once more markets open up and protecting margins, the importance of liquidity and avoiding debt. Fighting for reform. Experiential retail. Encouraged by the critical mass of the States and...

MSOhmy! The US cannabis space is at least 10x the size of Canadian market - and growing. Recent earnings for cannabis companies bear this out in a tale of two countries, with the US winning. Dan Ahrens, AdvisorShares COO and PM, returns to the show to discuss why stock selection matters, index based doesn't make sense for cannabis and avoiding Canada with exception. Cannabis ballot initiatives pas...

During a recessionary environment is historically when VCs make a ton of money. Narbe Alexandrian, President and CEO of Canopy Rivers, the venture capital arm of Canopy Growth, returns to the show. We discuss its portfolio, TerrAscend capitalizing on New Jersey going legal, and building one's thesis in the cannabis market. We also cover creating brand equity, being customer obsessed and finding th...

For cannabis legislation, worth focusing less on Presidential election, more on the Senate. Majority of Americans support cannabis legalization - what other topic has such unified opinion? So asks Anthony Coniglio, CEO of NewLake Capital, a cannabis real-estate investment vehicle with tenants across the supply chain in the U.S. We discuss the value of real estate, how NewLake differs from IIPR and...

Today's guest is the co-founder, CEO and CIO of Cambria Investment Management, Meb Faber. He has authored numerous white papers and books on factor-based portfolio construction and favors value- and momentum-tilted strategies in Cambria's 12 ETFs, as well as in the firm's separately managed accounts. The Cambria Cannabis ETF (TOKE) is currently Cambria's only foray into thematic investing - which...

We know not all states have legal cannabis and taxes are still being spent to keep people in jail for cannabis charges - and while there is extreme wealth in the industry not enough is being done to create change. Stormy Simon - after a successful 15 years at Overstock.com - opened her eyes to the power of the cannabis plant - and after a stint as High Times' CEO - decided to run for Utah's House...

As the cannabis industry continues to mature, many companies are reckoning with necessary evolutions. George Allen, formerly of Acreage and a friend of the show, joins Rena Sherbill to discuss the MSO scene and some of the myths surrounding the US cannabis industry. George always liked Indus Holdings' assets, but the company had made some mistakes before he came on board. Now it's operating at an...

Marie Montmarquet, co-founder of MD Numbers, talks to Rena Sherbill about the advantages of running a small family business. Avoiding over-corporatization, staying focused on the details, but knowing partnership may be inevitable. We also discuss the differences between Northern and Southern California cannabis cultures, willful vs woeful ignorance, failed policies and unavoidable unfriendly loans...

Frustrated by the 'business of medicine', Dr. Jessica Knox co-founded Doctors Knox, Inc., American Cannabinoid Clinics, and ADVENT Academy in order to build an endocannabinoidome care ecosystem that is science-based, patient-focused, and equity-driven. Dr. Knox joins Rena Sherbill to discuss the importance of leading with history and science, the concern around rescheduling cannabis and why the bi...

Max Simon, a cannabis thought leader, founder and CEO of Green Flower Media joins Rena Sherbill to discuss our favorite green flower. We discuss improving quality of life through cannabis, the job growth in the industry, running cannabis companies like a CPG company and why 'what cannabis stock should I buy' isn't the right question. We also cover the power of education and destigmatizing the cann...

With only 2 states, AYR Strategies is a top 5 EBITDA company and from a profit margin perspective, second in the industry. We're now in cannabis 2.0 which means more discipline from companies and investors. The winners have access to capital, bit everyone else is excluded. Jon Sandelman, AYR's CEO, returns to the show discuss with Rena Sherbill why culture and vision matter and why you can't build...

Though much of the US and Canadian cannabis space is focused on the adult-use/rec market, Africa, Europe, and Asia (most of the world!) are more focused on the medical side and that's where the legal industry is being established. David Parry, CEO of Cannsun Medhel, joins the show to talk about the medical side of cannabis, and focusing on Asia, Europe and Africa. Learning from indigenous communit...

We cover many fundamental questions in this deep, broad and colorful conversation with two terrific Seeking Alpha authors and investors in the cannabis space: James V. Baker and Julian Lin. Why there is time for current MSOs to build a moat, importance of passing MORE Act, descheduling the plant and why getting rid of 280E gives the industry life. Fallacy of free cash flow, MSO rollups, generating...